Experienced in Alveolar Soft Part Sarcoma

Dr. Habib M. Ghaddar

Hematology Oncology | Oncology | Palliative Medicine
Texas Oncology PA
1330 E 6th St, Suite 204, 
Weslaco, TX 
Accepting New Patients
Offers Telehealth
Experienced in Alveolar Soft Part Sarcoma
Texas Oncology PA
1330 E 6th St, Suite 204, 
Weslaco, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Habib Ghaddar is a Hematologist Oncology specialist and an Oncologist in Weslaco, Texas. Dr. Ghaddar is rated as an Experienced provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Pleuropulmonary Blastoma, and Thymic Epithelial Tumor. Dr. Ghaddar is currently accepting new patients.

His clinical research consists of participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Oncology
Palliative Medicine
Licenses
Internal Medicine in TX
Hospital Affiliations
Vhs Harlingen Hospital Company LLC
Knapp Medical Center
Doctors Hosptal At Renaissance
Languages Spoken
English
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
MVP Health
  • EPO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

TEXAS ONCOLOGY PA
1330 E 6th St, Suite 204, Weslaco, TX 78596
Other Locations
TEXAS ONCOLOGY PA
2121 Pease St, Suite 101, Harlingen, TX 78550
TEXAS ONCOLOGY PA
1901 S 2nd St, Mcallen, TX 78503
TEXAS ONCOLOGY PA
2026 S Jackson St, Jacksonville, TX 75766
TEXAS ONCOLOGY PA
7848 Gateway Blvd E, El Paso, TX 79915
TEXAS ONCOLOGY PA
1901 S Col Rowe Blvd, Mcallen, TX 78503

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes in Patients With Stage IV, 1L Non-Small Cell Lung Cancer to Determine Eligibility for the KEAPSAKE Clinical Trial (NCT04265534)
Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes in Patients With Stage IV, 1L Non-Small Cell Lung Cancer to Determine Eligibility for the KEAPSAKE Clinical Trial (NCT04265534)
Enrollment Status: Terminated
Publish Date: March 13, 2023
A Phase 1/2 Study of Pegzilarginase (AEB1102, Co-ArgI-PEG) in Combination With Pembrolizumab in the Treatment of Patients With Extensive Disease (ED) Small Cell Lung Cancer (SCLC)
A Phase 1/2 Study of Pegzilarginase (AEB1102, Co-ArgI-PEG) in Combination With Pembrolizumab in the Treatment of Patients With Extensive Disease (ED) Small Cell Lung Cancer (SCLC)
Enrollment Status: Completed
Publish Date: November 04, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Randomized Phase 2 Trial of AM0010 in Combination With Nivolumab vs. Nivolumab Alone as Second-Line Therapy in Subjects With Stage IV / Metastatic Wild Type Non-Small Cell Lung Cancer and Low Tumor Expression of PD-L1
A Randomized Phase 2 Trial of AM0010 in Combination With Nivolumab vs. Nivolumab Alone as Second-Line Therapy in Subjects With Stage IV / Metastatic Wild Type Non-Small Cell Lung Cancer and Low Tumor Expression of PD-L1
Enrollment Status: Terminated
Publish Date: September 11, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2
View 2 Less Clinical Trials
Similar Doctors
Experienced in Alveolar Soft Part Sarcoma
Dr. Eugenio G. Galindo
Hematology Oncology | Hematology | Oncology
Experienced in Alveolar Soft Part Sarcoma
Dr. Eugenio G. Galindo
Hematology Oncology | Hematology | Oncology

Mcallen Oncology PA

5401 N G St, Suite 3, 
Mcallen, TX 
 (15.5 miles away)
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Eugenio Galindo is a Hematologist Oncology specialist and a Hematologist in Mcallen, Texas. Dr. Galindo is rated as a Distinguished provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Testicular Yolk Sac Tumor. Dr. Galindo is currently accepting new patients.

Experienced in Alveolar Soft Part Sarcoma
Dr. Ghanem Daghestani
Hematology Oncology | Oncology | Hematology
Experienced in Alveolar Soft Part Sarcoma
Dr. Ghanem Daghestani
Hematology Oncology | Oncology | Hematology

Texas Oncology PA

1901 S 2nd St, 
Mcallen, TX 
 (15.4 miles away)
956-687-5150
Languages Spoken:
English, Arabic, French, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Ghanem Daghestani is a Hematologist Oncology specialist and an Oncologist in Mcallen, Texas. Dr. Daghestani is rated as an Advanced provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Paget Disease of the Breast, and Inflammatory Breast Cancer. Dr. Daghestani is currently accepting new patients.

Experienced in Alveolar Soft Part Sarcoma
Dr. Nabeel Sarhill
Hematology Oncology | Addiction Medicine | Oncology
Experienced in Alveolar Soft Part Sarcoma
Dr. Nabeel Sarhill
Hematology Oncology | Addiction Medicine | Oncology

Texas Oncology PA

2121 Pease St, Suite 101, 
Harlingen, TX 
 (19.1 miles away)
956-425-8845
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Nabeel Sarhill is a Hematologist Oncology specialist and an Addiction Medicine provider in Harlingen, Texas. Dr. Sarhill is rated as an Advanced provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Pleuropulmonary Blastoma, Bone Marrow Aspiration, and Endoscopy. Dr. Sarhill is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ghaddar's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 89 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile